Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real‐World Data: A Scoping Review

• Oluwadamilola ONASANYACarelon Research (United States)
• Seyed Hamidreza MahmoudpourMerck Healthcare KGaA, Darmstadt (Germany)
• Benjamin A. BatesRutgers, The State University of New Jersey
• Irene M. ShuiMerck & Co., Inc., Rahway, NJ, USA (United States)
• Geoffrey LiuUniversity of Toronto
• Eng Hooi TanNuffield Orthopaedic Centre
• Yi‐Hsin YangNational Health Research Institutes
• Maribel SalasRutgers, The State University of New Jersey
• Joseph Olusesan FadareEkiti State University
• Dimitri BennettTakeda (Japan)
• Paula Lana de Miranda DrummondEzequiel Dias Foundation
• Ju‐Young ShinSungkyunkwan University
• Sonia Guleria
• J. R.Janssen Research & Development (United States)
• Manila HadaMerck & Co., Inc., Rahway, NJ, USA (United States)
• Hélène Denis
• Soko SetoguchiRutgers, The State University of New Jersey
• Ilse TruterNelson Mandela University
• Luciane Cruz LopesUniversidade de Sorocaba
• Ruth Wangia DixonCarelon Research (United States)